Advocacy intelligence hub — real-time data for patient organizations
DORC ILM-Blue: FDA approved
TissueBlue (Brilliant Blue G Ophthalmic Solution) 0.025% is indicated to selectively stain the internal limiting membrane (ILM).
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
DORC ILM-Blue
Dutch Ophthalmic Research Center International BV
DORC ILM-Blue
(Brilliant Blue G Ophthalmic Solution 0.025%)Orphan drugDutch Ophthalmic Research Center International BV
Browse all Rare genetic ophthalmic disorder with cortical involvement news →
View all Rare genetic ophthalmic disorder with cortical involvement specialists →